Anemarsaponin E is primarily studied for its anti-inflammatory and neuroprotective properties. It has shown potential in inhibiting pro-inflammatory cytokines, making it a candidate for research in treating chronic inflammatory diseases. It also exhibits activity in protecting neuronal cells, suggesting possible applications in neurodegenerative conditions such as Alzheimer's disease. Additionally, Anemarsaponin E has demonstrated antidiabetic effects by enhancing insulin sensitivity and glucose uptake in preclinical models. Its ability to modulate immune responses and induce apoptosis in certain cancer cell lines further supports its exploration in oncology and autoimmune disorders. Most applications remain in the experimental stage, primarily in vitro and animal studies.